Digital Health Today shines a spotlight on the entrepreneurs, innovators, and organizations that dare to revolutionize healthcare
Today I’m talking with Harry Rowland, co-founder and CEO of Endotronix. Endotronix was founded in 2007 and is developing an implantable pressure sensor that can be placed in the pulmonary artery outside the heart.
Dr. Rowland has led the company’s innovation, strategy and technology developments since the project began and has raised millions of dollars in funding. In this episode, he shares the exciting new prospects this technology offers as part of a complete health system that provides tools and feedbacks to help extend and improve patient’s lives.
Today’s Topics:
Links and Resources Mentioned:
An important message from RadioPublic
Women and girls in low/middle-income countries are facing an urgent unmet need for modern contraception. This World Contraception Day, join guest host Sophie Park, Managing Director at G4A …
The Digital Medicine Society (DiMe) and Moffitt Cancer Center have announced they are co-hosting CancerX, a new public-private partnership effort to rapidly accelerate the pace of cancer …
In this coffee talk with AmalgamRX we dive into the challenges being faced by health systems as they work to assess, develop, and implement solutions …
I’m glad to be back on the mic and bringing you this special episode of Digital Health Today 360. Why is this episode special? Let me explain.
One of the goals of the Digital Health Today …
Technology is under the microscope, as are the behaviors of the people who develop and deploy it.
As technology impacts virtually every aspect of …
You can listen to episodes right here on the website, or if you prefer, in a podcast app. Listening in an app makes it easier to keep track of what you’ve already heard, listen without using your data plan and many other conveniences.